UH Seidman Cancer Center | Aug. 16, 2025
Empowering Patients with Knowledge and Support
Saturday, August 16, 2025 |Time: 8:30 AM ET | 7:30 AM CT | 6:30 AM MT | 5:30 AM PT
About the Symposium
This Living with Melanoma Symposium brings together leading experts from the University Hospitals Seidman Cancer Center and Case Western Reserve University School of Medicine to share the latest advances in melanoma treatment, clinical trials, and patient support resources. Whether you are newly diagnosed, undergoing treatment, or a survivor, this symposium offers practical knowledge, inspiration, and community support to help you navigate your melanoma journey with confidence.
What You’ll Learn
- Advances in immunotherapy and how first- and second-line treatments are determined
- Treatment options for inoperable melanoma tumors
- Importance of dermatologic surveillance in melanoma care
- When surgical resection and immunotherapy are indicated
- Clinical trials: understanding the why, when, and which
- Patient resources and support through AIM at Melanoma
- Insights from a patient panel sharing real-life experiences
Individual Presentations
Immunotherapy: What Is It and How Do We Determine First Line vs Second Line Treatments?
Dr. Gary Schwartz, MD
Director, Case Comprehensive Cancer Center
Vice Dean for Oncology, School of Medicine
Gertrude Donnelly Hess MD Professor in Oncology Research
Treatment Options for Inoperable Melanoma Tumors
Iris Y. Sheng, MD
Attending Physician (Division of Cutaneous and GU Oncology)
University Hospitals Seidman Cancer Center
Assistant Professor of Medicine
Division of Hematology and Oncology
Case Western Reserve University School of Medicine
Dermatologic Surveillance in Melanoma
Mara Beveridge, MD
Senior Attending Physician (Division of Dermatology)
University Hospitals Seidman Cancer Center
Assistant Professor of Medicine
Division of Dermatology
Case Western Reserve University School of Medicine
Surgically Resectable Melanoma: When is Immunotherapy Indicated?
Luke Rothermel, MD, MPH
Co-Director Sarcoma and Melanoma Disease Team
Chief, Section of Soft Tissue and GI Surgery
University Hospitals Cleveland Medical Center
Associate Professor of Surgery
Division of Surgical Oncology
Case Western Reserve University School of Medicine
Clinical Trials: The Why, When and Which of Clinical Trials
Ankit Mangla, MD
Co-Director Sarcoma and Melanoma Disease Team
University Hospitals Seidman Cancer Center
Associate Professor of Medicine
Division of Hematology and Oncology
Case Western Reserve University School of Medicine